INHIBITORY CHECKPOINT MOLECULE

Clinical trials for INHIBITORY CHECKPOINT MOLECULE explained in plain language.

Never miss a new study

Get alerted when new INHIBITORY CHECKPOINT MOLECULE trials appear

Sign up with your email to follow new studies for INHIBITORY CHECKPOINT MOLECULE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

New hope to slow advanced prostate cancer

Disease control Ongoing

This study is testing whether adding an experimental immunotherapy drug called lorigerlimab to standard chemotherapy (docetaxel) can help men with advanced prostate cancer live longer without their cancer getting worse. About 150 men whose prostate cancer has spread and stopped r…

Matched conditions: INHIBITORY CHECKPOINT MOLECULE

Phase: PHASE2 • Sponsor: MacroGenics • Aim: Disease control

Last updated Apr 04, 2026 06:37 UTC

INHIBITORY CHECKPOINT MOLECULE

Get alerted when new INHIBITORY CHECKPOINT MOLECULE trials appear

New hope to slow advanced prostate cancer